XML 20 R2.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 81,467 $ 58,064
Short-term marketable securities 211,474 222,767
Receivables from collaborative arrangements 15,868 11,996
Receivables from licensing arrangements   10,000
Amounts due from TRC, LLC 53,799 28,574
Prepaid clinical and development services 20,374 2,736
Other prepaid and current assets 10,359 4,351
Total current assets 393,341 338,488
Property and equipment, net 16,422 12,644
Long-term marketable securities   4,985
Operating lease assets 43,260 46,604
Equity in net assets of TRC, LLC 12,750  
Tax receivable   3,682
Restricted cash 833 833
Other assets 2,451 1,590
Total assets 469,057 408,826
Current liabilities:    
Accounts payable 6,775 4,758
Accrued personnel-related expenses 35,238 28,180
Accrued clinical and development expenses 28,799 17,587
Accrued general and administrative expenses 6,048 4,394
Accrued interest payable 3,974 5,659
Current portion of non-recourse notes due 2035, net 19,334  
Current portion of non-recourse notes due 2033, net   9,851
Operating lease liabilities 9,867 7,762
Deferred revenue 11,523 31,575
Other accrued liabilities 2,013 1,937
Total current liabilities 123,571 111,703
Convertible senior notes due 2023, net 226,963 225,890
Non-recourse notes due 2035, net 372,873  
Non-recourse notes due 2033, net   219,300
Long-term operating lease liabilities 47,220 47,725
Long-term deferred revenue 348 6,761
Other long-term liabilities 1,833 21,287
Commitments and contingencies
Shareholders' Deficit    
Preferred shares, $0.00001 par value: 230 shares authorized, no shares issued or outstanding
Ordinary shares, $0.00001 par value: 200,000 shares authorized; 64,328 and 57,015 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively 1 1
Additional paid-in capital 1,222,818 1,024,614
Accumulated other comprehensive income 47 145
Accumulated deficit (1,526,617) (1,248,600)
Total shareholders' deficit (303,751) (223,840)
Total liabilities and shareholders' deficit $ 469,057 $ 408,826